ArticlePLoS computational biology2026
Edge-aware GAT-based protein binding sites prediction.
Article in PLoS computational biology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
Abstract
Accurate identification of protein binding sites is crucial for understanding biomolecular interaction mechanisms and for the rational design of drug targets. Traditional predictive methods often struggle to balance prediction accuracy with computational efficiency when capturing complex spatial conformations. To address this challenge, we propose an Edge-aware Graph Attention Network (Edge-aware GAT) model for the fine-grained prediction of binding sites across various biomolecules, including proteins, DNA/RNA, ions, ligands, and lipids. Our method constructs atom-level graphs and integrates multidimensional structural features, including geometric descriptors, DSSP-derived secondary structure, and relative solvent accessibility (RSA), to generate spatially aware embedding vectors. By incorporating interatomic distances and unit direction vectors as geometric edge features within the attention mechanism, the model enhances local structural representation without claiming strict SE(3)- or E(3)-equivariance. On benchmark datasets, our model achieves a ROC-AUC of 0.93 for protein-protein binding site prediction and shows competitive performance among the evaluated structure-based atomic-level models. The use of geometry-aware edge attention and residue-level attention pooling further improves both binding site localization and the capture of local structural details. Visualizations using PyMOL confirm the model's practical utility and interpretability. To facilitate community access and application, we have deployed a publicly accessible web server at http://119.45.201.89:5000/. In summary, our approach offers an efficient structure-based framework that balances prediction accuracy, generalization, and interpretability for identifying functional sites in proteins.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.